Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HDL in CKD—The Devil Is in the Detail

22 Feb 2018

Abstract excerpt

The picture of HDL cholesterol (HDL-C) as the "good" cholesterol has eroded. This is even more surprising because there exists strong evidence that HDL-C is associated with cardiovascular disease (CVD) in the general population as well as in patients with impairment of kidney function and/or progression of CKD. However, drugs that dramatically increase HDL-C have mostly failed to decrease CVD events. Furthermore,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholesterol and Lipid Metabolism
Share to Diabetes, Cardiovascular Risks, and Lipoproteins
Share to Lipoproteins and Cardiovascular Health

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29472417
DOI: 10.1681/asn.2017070798

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HDL in CKD—The Devil Is in the DetailPMID 29472417Read ↗

HDL and chronic kidney diseaseSemantic proximity Read ↗

HDL in the 21st Century: A Multifunctional Roadmap for Future HDL ResearchSemantic proximity Read ↗

High-Density Lipoproteins and the Kidney.Semantic proximity Read ↗

HDL in Atherosclerotic Cardiovascular Disease: In Search of a Role.Semantic proximity Read ↗

HDL, Atherosclerosis, and Emerging TherapiesSemantic proximity Read ↗

High-Density LipoproteinsSemantic proximity Read ↗

High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular riskSemantic proximity Read ↗

Advances in the Study of the Antiatherogenic Function and Novel Therapies for HDLSemantic proximity Read ↗

High-density lipoprotein subfractions--what the clinicians need to know.Semantic proximity Read ↗

HDL Is Not Dead YetSemantic proximity Read ↗

Treating low HDL--from bench to bedside.Semantic proximity Read ↗

HDL quality and functionality: what can proteins and genes predict?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.